Close

Prof Andrew Briggs

Professor in Health Economics

United Kingdom

Tel.
+44 (0)207 927 2348
Andrew is a Professor of Health Economics at the London School of Hygiene & Tropical Medicine and co-director of the Global Health ECOnomics (GHECO) Centre at the School. Previously, he held the William R Lindsay Chair in Health Economics at the University of Glasgow.

Andrew has expertise in all areas of health economic evaluation -- he has published over 300 articles in the peer-reviewed literature. He has particularly focused on statistical methods for cost-effectiveness analysis. This includes statistical methods for estimation of parameters for cost-effectiveness models as well as statistical analysis of cost-effectiveness alongside clinical trials. He also has a more general interest in epidemiological methods, in particular the use of prognostic scoring methods for predicting health outcomes and the relationship with heterogeneity in cost-effectiveness.

Andrew took a leadership role as co-chair of the Joint Society for Medical Decision Making (SMDM) and International Society for PharmacoEconomics and Outcomes Research (ISPOR) Task Force on Modelling Methods. The Task Force, which was responsible for producing a set of seven papers covering all aspects of modelling methods applied to medical decision making and health technology assessment. He is also the author of two successful textbooks, one published by OUP entitled Decision Modelling for Health Economic Evaluation, and another published by Wiley entitled Statistical Methods for Cost-Effectiveness Analysis.

Affiliations

Department of Health Services Research and Policy
Faculty of Public Health and Policy

Centres

Global Health Economics Centre

Teaching

Together with Zia Sadique, Andrew is module organiser for C1-1501 Economic Evaluation, part of the MSc Public Health at the School. He also co-leads two continuing professional development short courses with Mark Sculpher from University of York: a Foundations course and an Advanced course in Decision Modelling for Health Economic Evaluation.

Selected Publications

Cost-Effectiveness of Total Neoadjuvant Therapy With Selective Nonoperative Management for Locally Advanced Rectal Cancer: Analysis of Data From the Organ Preservation for Rectal Adenocarcinoma Trial.
Widmar, M; McCain, M; Mishra Meza, A; Ternent, C; BRIGGS, A; Garcia-Aguilar, J;
2024
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
An Attribution of Value Framework for Combination Treatments.
BRIGGS, AH; Doyle-Connolly, A; Schneider, J; Podkonjak, T; Taylor, H; Roffe, E; Low, E; Davis, S; Kaiser, M; Hatswell, AJ; Rabin, N;
2024
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study.
Leavy, OC; Russell, RJ; Harrison, EM; Lone, NI; Kerr, S; Docherty, AB; Sheikh, A; Richardson, M; Elneima, O; Greening, NJ; Harris, VC; Houchen-Wolloff, L; McAuley, HJ C; Saunders, RM; Sereno, M; Shikotra, A; Singapuri, A; Aul, R; Beirne, P; Bolton, CE; Brown, JS; Choudhury, G; Diar Bakerly, N; Easom, N; Echevarria, C; ... Evans, RA.
2024
ERJ open research
Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populations.
Lugo-Palacios, DG; BIDULKA, P; O'Neill, S; CARROLL, O; Basu, A; Adler, A; DíazOrdaz, K; BRIGGS, A; GRIEVE, R;
2024
Health economics
Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial.
Gögenur, M; Rosen, AW; Iveson, T; Kerr, RS; Saunders, MP; Cassidy, J; Tabernero, J; Haydon, A; Glimelius, B; Harkin, A; Allan, K; Pearson, S; Boyd, KA; BRIGGS, AH; Waterston, A; Medley, L; Ellis, R; Dhadda, AS; Harrison, M; Falk, S; Rees, C; Olesen, RK; Propper, D; Bridgewater, J; Azzabi, A; ... Holländer, NH.
2024
JAMA surgery
Healthcare utilisation in people with long COVID: an OpenSAFELY cohort study.
Lin, L-Y; Henderson, AD; CARLILE, O; Dillingham, I; Butler-Cole, BF C; MARKS, M; BRIGGS, A; JIT, M; TOMLINSON, LA; Bates, C; Parry, J; Bacon, SC J; GOLDACRE, B; Mehrkar, A; MacKenna, B; OpenSAFELY Collaborative,; EGGO, RM; HERRETT, E;
2024
BMC medicine
Health Economic Evaluation of Lung Cancer Screening Using a Diagnostic Blood Test: The Early Detection of Cancer of the Lung Scotland (ECLS).
Robles-Zurita, JA; McMeekin, N; Sullivan, F; Mair, FS; BRIGGS, A;
2024
Current oncology (Toronto, Ont.)
Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis.
Henderson, AD; Butler-Cole, BF; Tazare, J; TOMLINSON, LA; MARKS, M; JIT, M; BRIGGS, A; Lin, L-Y; CARLILE, O; Bates, C; Parry, J; Bacon, SC; Dillingham, I; Dennison, WA; COSTELLO, RE; Wei, Y; Walker, AJ; Hulme, W; GOLDACRE, B; Mehrkar, A; MacKenna, B; OpenSAFELY Collaborative,; HERRETT, E; Eggo, RM;
2024
EClinicalMedicine
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
BIDULKA, P; Lugo-Palacios, DG; CARROLL, O; O'NEILL, S; Adler, AI; Basu, A; Silverwood, RJ; BARTLETT, JW; NITSCH, D; Charlton, P; BRIGGS, AH; SMEETH, L; DOUGLAS, IJ; Khunti, K; GRIEVE, R;
2024
BMJ
See more information